Skip to main content
Skip to main content
AMWL logo

American Well Corporation (AMWL) (AMWL)

For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

American Well Corporation (AMWL) (AMWL) trades at $5.51 with AI Score 52/100 (Hold). American Well Corporation (AMWL) is a telehealth software company enabling digital healthcare delivery. Market cap: 92M, Sector: Healthcare.

Last analyzed: Feb 8, 2026
American Well Corporation (AMWL) is a telehealth software company enabling digital healthcare delivery. They provide a platform for various medical services and telemedicine equipment.
52/100 AI Score Target $5.00 (-9.3%) MCap 92M Vol 27K

American Well Corporation (AMWL) (AMWL) Healthcare & Pipeline Overview

CEOIdo Schoenberg
Employees877
HeadquartersBoston, MA, US
IPO Year2020

American Well Corporation (AMWL) pioneers digital healthcare delivery through its comprehensive telehealth platform, offering diverse medical services and telemedicine solutions, positioning it as a key player in the rapidly expanding virtual care market despite current profitability challenges.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Feb 8, 2026

Investment Thesis

Investing in American Well Corporation (AMWL) presents a speculative opportunity in the growing telehealth market. While the company's current P/E ratio of -0.63 and a negative profit margin of -42.8% raise concerns, the increasing adoption of telehealth services could drive future growth. Key value drivers include expanding partnerships with healthcare providers and insurers, increasing utilization of telehealth services, and potential cost savings from virtual care delivery. The company's beta of 1.40 suggests higher volatility compared to the market. Upcoming catalysts include new product launches and strategic collaborations. Success hinges on Amwell's ability to achieve profitability and capture a larger share of the telehealth market.

Based on FMP financials and quantitative analysis

Key Highlights

  • Market Cap of $0.07B reflects its current valuation in the telehealth market.
  • Negative P/E ratio of -0.63 indicates current unprofitability.
  • Gross Margin of 39.7% demonstrates the potential for profitability with increased scale.
  • Profit Margin of -42.8% highlights the challenges in achieving profitability in the competitive telehealth market.
  • Beta of 1.40 suggests higher volatility compared to the market.

Competitors & Peers

Strengths

  • Comprehensive telehealth platform with diverse service offerings.
  • Established partnerships with health systems and insurers.
  • Proprietary technology and software solutions.
  • Experienced management team with expertise in telehealth.

Weaknesses

  • Negative profit margin and ongoing losses.
  • High competition in the telehealth market.
  • Dependence on regulatory changes and reimbursement policies.
  • Relatively small market capitalization.

Catalysts

  • New product launches and platform enhancements.
  • Expansion of partnerships with health systems and insurers.
  • Increasing utilization of telehealth services.
  • Positive regulatory changes and reimbursement policies.

Risks

  • Increasing competition from other telehealth providers.
  • Changes in regulatory policies and reimbursement rates.
  • Data security and privacy breaches.
  • Negative profit margin and ongoing losses.
  • Dependence on technology and internet connectivity.

Growth Opportunities

  • Expanding partnerships with health systems and insurers: Amwell can drive growth by forging deeper integrations with established healthcare providers and insurance companies. These partnerships can increase the reach of Amwell's telehealth platform and drive higher utilization rates. The market for telehealth partnerships is substantial, with health systems and insurers increasingly seeking to expand their virtual care offerings. Timeline: Ongoing.
  • Increasing utilization of telehealth services: Amwell can focus on driving greater adoption of its telehealth services among patients and providers. This can be achieved through targeted marketing campaigns, educational initiatives, and user-friendly platform enhancements. The market for telehealth services is projected to reach billions of dollars in the coming years, driven by increasing demand for convenient and accessible healthcare. Timeline: Ongoing.
  • Developing new telehealth solutions: Amwell can expand its product offerings to include new telehealth solutions that address unmet needs in the healthcare market. This could include specialized programs for chronic disease management, mental health support, and remote patient monitoring. The market for specialized telehealth solutions is growing rapidly, driven by the increasing prevalence of chronic diseases and the need for more personalized care. Timeline: Ongoing.
  • Leveraging artificial intelligence and machine learning: Amwell can integrate AI and machine learning technologies into its platform to improve the efficiency and effectiveness of telehealth services. This could include using AI to triage patients, personalize treatment plans, and automate administrative tasks. The market for AI in healthcare is projected to reach billions of dollars in the coming years, driven by the potential to improve patient outcomes and reduce healthcare costs. Timeline: Ongoing.
  • Expanding into new geographic markets: Amwell can expand its operations into new geographic markets to reach a wider customer base. This could include targeting international markets with high demand for telehealth services. The global telehealth market is growing rapidly, driven by increasing demand for convenient and accessible healthcare solutions in developing countries. Timeline: Ongoing.

Opportunities

  • Expanding partnerships with health systems and insurers.
  • Increasing utilization of telehealth services.
  • Developing new telehealth solutions for chronic disease management and mental health.
  • Leveraging AI and machine learning to improve efficiency and effectiveness.

Threats

  • Increasing competition from other telehealth providers.
  • Changes in regulatory policies and reimbursement rates.
  • Data security and privacy concerns.
  • Potential for technological obsolescence.

Competitive Advantages

  • Established telehealth platform with a wide range of services.
  • Partnerships with leading health systems and insurers.
  • Proprietary technology and software solutions.
  • Brand recognition and reputation in the telehealth market.

About AMWL

American Well Corporation, now known as Amwell, was founded in 2006 with the mission of transforming healthcare delivery through technology. Recognizing the potential of telehealth to improve access and convenience, the company developed a platform that connects patients with doctors and other healthcare providers remotely. Over the years, Amwell has expanded its offerings to include a wide range of services, from urgent care and scheduled visits to specialized medical consultations such as telestroke and behavioral health. The company's platform supports various care settings, including homes, schools, and retail clinics. Amwell also provides telemedicine equipment, such as carts, peripherals, and kiosks, to facilitate virtual care delivery. Headquartered in Boston, Massachusetts, Amwell has established itself as a leading telehealth provider, partnering with health systems, insurers, and employers to deliver digital healthcare solutions. Despite its innovative approach, Amwell faces competition from other telehealth providers and traditional healthcare models, requiring continuous adaptation and strategic partnerships to maintain its market position.

What They Do

  • Provides a telehealth platform for digital healthcare delivery.
  • Offers urgent care services through virtual consultations.
  • Facilitates scheduled visits with healthcare providers remotely.
  • Delivers acute behavioral health services via telehealth.
  • Supports telestroke consultations for timely stroke care.
  • Offers pediatric telehealth services for children's healthcare needs.
  • Provides telemedicine equipment such as carts and peripherals.

Business Model

  • Generates revenue through subscription fees from health systems and insurers.
  • Charges per-visit fees for telehealth consultations.
  • Sells telemedicine equipment to healthcare providers.
  • Offers software licensing for its telehealth platform.

Industry Context

American Well Corporation operates within the rapidly evolving telehealth industry. The market is driven by increasing demand for convenient and accessible healthcare solutions, advancements in technology, and favorable regulatory changes. The telehealth market is expected to continue growing at a rapid pace, driven by factors such as aging populations, rising healthcare costs, and increasing prevalence of chronic diseases. Competitors include companies like Advaxis (ADVM), Alexo Therapeutics (ALXO), Atyr Pharma (ATYR), Bionomics (BMEA), and Camping World Holdings (CAMP), each vying for market share with different approaches to telehealth services. Amwell's success depends on its ability to differentiate itself through technology, partnerships, and service offerings.

Key Customers

  • Health systems seeking to expand their virtual care offerings.
  • Insurers looking to reduce healthcare costs and improve access to care.
  • Employers providing telehealth benefits to their employees.
  • Patients seeking convenient and affordable healthcare services.
AI Confidence: 70% Updated: Feb 8, 2026

AMWL Financials

AMWL Price Today & Live Chart

American Well Corporation (AMWL) (AMWL) stock price: $5.51 (-0.12, -2.13%)

AMWL Latest News

AMWL Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AMWL.

Price Targets

Consensus target: $5.00

AMWL MoonshotScore

52/100

What does this score mean?

The MoonshotScore rates AMWL's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

American Well Corporation (AMWL) Healthcare Stock: Key Questions Answered

What does American Well Corporation do?

American Well Corporation (Amwell) operates as a telehealth software company that enables the digital delivery of care. They provide a platform connecting patients with healthcare providers for various services, including urgent care, scheduled visits, and specialized consultations. Amwell's platform supports different care settings, such as homes, schools, and retail clinics. They also offer telemedicine equipment like carts and peripherals, facilitating virtual care. Amwell generates revenue through subscription fees, per-visit charges, and equipment sales, positioning itself as a key player in the evolving telehealth market.

Is AMWL stock worth researching?

AMWL stock presents a speculative investment opportunity. While the company's negative P/E ratio and profit margin raise concerns, the growing telehealth market offers potential upside. Key factors to consider include Amwell's partnerships, utilization rates, and cost savings from virtual care. Investors should weigh the risks of competition and regulatory changes against the potential for future growth. A successful investment hinges on Amwell's ability to achieve profitability and capture a larger share of the telehealth market, making it a high-risk, high-reward opportunity.

What are the main risks for AMWL?

The main risks for AMWL include increasing competition in the telehealth market, which could pressure pricing and market share. Changes in regulatory policies and reimbursement rates could negatively impact revenue. Data security and privacy breaches pose a significant threat, potentially damaging the company's reputation and leading to financial losses. Additionally, AMWL faces the ongoing challenge of achieving profitability and managing its expenses. Dependence on technology and internet connectivity also presents a risk, as disruptions could impact service delivery.

What are the key factors to evaluate for AMWL?

American Well Corporation (AMWL) (AMWL) currently holds an AI score of 52/100, indicating moderate score. Analysts target $5.00 (-9% from $5.51). Key strength: Comprehensive telehealth platform with diverse service offerings. Primary risk to monitor: Increasing competition from other telehealth providers. This is not financial advice.

How frequently does AMWL data refresh on this page?

AMWL prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven AMWL's recent stock price performance?

Recent price movement in American Well Corporation (AMWL) (AMWL) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $5.00 implies 9% downside from here. Notable catalyst: Comprehensive telehealth platform with diverse service offerings. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider AMWL overvalued or undervalued right now?

Determining whether American Well Corporation (AMWL) (AMWL) is overvalued or undervalued requires examining multiple metrics. Analysts target $5.00 (-9% from current price), suggesting analysts see the stock near fair value. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying AMWL?

Before investing in American Well Corporation (AMWL) (AMWL), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .

Data provided for informational purposes only.

Analysis Notes
  • Financial data is based on the most recent available information.
  • The telehealth market is subject to rapid changes and regulatory uncertainties.
Data Sources

Popular Stocks